Maastricht IBS Cohort
NCT00775060 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2016-04-07
Summary
To set up a cohort of at least 400 IBS patients in order to identify different patient subgroups according to phenotypical and genotypical patterns and
To set up a biobank for future translational studies on the pathophysiology of IBS, in order to identify genetic factors to unravel the pathogenesis of IBS and to provide novel therapeutic targets.
Conditions
- Irritable Bowel Syndrome
Sponsors & Collaborators
-
Maastricht University Medical Center
lead OTHER
Principal Investigators
-
Ad Masclee, MD, PhD · Maastricht University Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2024-09-30
- Completion
- 2024-09-30
Countries
- Netherlands
Study Locations
More Related Trials
-
The Value of Bio-electrical Impedance Analysis in Irritable Bowel Syndrome
NCT05744258 ·Status: COMPLETED ·Phase: NA
-
Irritable Bowel Syndrome Regional Cohort
NCT06900491 ·Status: RECRUITING
-
Phenotyping IBS: Perceptions and Modulations of Visceral Sensations
NCT02693730 ·Status: COMPLETED
-
Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating
NCT02299973 ·Status: COMPLETED ·Phase: NA
-
The Effect of Dietary Intervention on Symptoms, Epigenetics, and Gut Microbiota in IBS
NCT03306381 ·Status: COMPLETED ·Phase: NA
-
ConfocAl endomicroSCopy bAsed Diet Trial in IBS
NCT05097872 ·Status: RECRUITING ·Phase: NA
-
Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome
NCT02249169 ·Status: COMPLETED
-
The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT02512146 ·Status: UNKNOWN
-
Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy Individuals
NCT07212569 ·Status: NOT_YET_RECRUITING
-
Small and Large Bowel Transit Tests Using MRI (Study 1)
NCT01534507 ·Status: COMPLETED
-
Assessing Associations Between IBS Symptoms, Nutrition and QoL in IBS Patients Using a Questionnaire
NCT03824821 ·Status: COMPLETED
-
Genetic Determinism of Epithelial Barrier Defects in Irritable Bowel Syndrome
NCT02841878 ·Status: WITHDRAWN ·Phase: NA
-
The Effect of a Low FODMAP Diet in Irritable Bowel Syndrome Patients
NCT04373304 ·Status: UNKNOWN ·Phase: NA
-
The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
NCT01072903 ·Status: COMPLETED
-
Characterizing Protein Biomarkers of Post-infection Irritable Bowel Syndrome
NCT06032117 ·Status: COMPLETED
-
The Effect of a Multispecies Probiotic on Hypersensitivity in Irritable Bowel Syndrome (IBS) Patients
NCT00702026 ·Status: COMPLETED ·Phase: NA
-
"Functional Bowel Disorder. Investigation in General Practice"
NCT01153295 ·Status: COMPLETED ·Phase: NA
-
Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of Young Adults.
NCT01854060 ·Status: COMPLETED
-
Investigating the Gut Microbiome and Symptomology in IBS
NCT06708533 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Single-center Exploratory Study of the Intestinal Microbiota in Patients Treated for Irritable Bowel Syndrome With Predominant Constipation and Methane Production
NCT06801184 ·Status: RECRUITING
-
Patient Attributes for Optimal Treatment Outcome in Irritable Bowel Syndrome.
NCT01297556 ·Status: UNKNOWN ·Phase: NA
-
Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome
NCT02981888 ·Status: COMPLETED
-
Brain-Gut-Microbiota Interaction in IBS
NCT04296552 ·Status: UNKNOWN ·Phase: NA
-
Understanding Abdominal Pain in IBD and IBS
NCT04020835 ·Status: UNKNOWN
-
A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)
NCT01340053 ·Status: COMPLETED ·Phase: PHASE2